Advanced therapies in Europe Phacilitate

Advanced Therapies Opportunities in Europe

An overview of clinical, investment and market approval activity in Europe

The European advanced therapies market may not be valued as much as the US or growing as fast as other regions but it is a hotbed of activity and opportunity. It stands to reason that a region renowned for its long-standing academic institutions and a long history of discovery and collaborative work should be at the forefront of such an innovative industry.


For instance, did you know that over a third of phase III advanced therapy trials are conducted in Europe?


This infographic is a compilation of some of the clinical, R&D, financial and regulatory activity across Europe. We're also keeping track of the current stories and goings-on across the region in real-time here.